Role of tumour necrosis factor-alpha (TNF-α) in the induction of HIV-1 gp120-mediated CD4+ T cell anergy

Clinical and Experimental Immunology

Volumn 109, Issue 1, 1997, Pages 41-46

  Kaneko, H ^a   Hishikawa, T ^a   Sekigawa, I ^b   Hashimoto, H ^a   Okumura, K ^a   Kaneko, Y ^c  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^c AJINOMOTO CO INC   (Japan)

Author keywords

HIV 1 gp120; T cell energy; TNF

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; RECOMBINANT PROTEIN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN SPECIFICITY; ARTICLE; CLONAL ANERGY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030835306     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4231325.x     Document Type: Article

References (41)

1. Shearer GM, Salahuddin SZ, Markham PD et al. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. J Clin Invest 1985; 76:1699-704.
2. Shearer GM, Bernstein DC, Tung KSK, Via CS, Redlield R, Salahuddin SZ, Gallo RC. A model for the selective loss of major histocompalibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J Immunol 1986; 137:2514-21.
3. + T helper cell depletion occurs. J Clin Invest 1988; 82:1908-14.
4. Gruters RA, Terpstra FG, De Jong R, Van Noesel CJM, Van Lier RAW, Miedema F. Selective loss of T cell functions in different stages of HIV infection. Eur J Immunol 1990; 20:1039-44.
5. Miedema F, Meyaard L, Koot M et al. Changing virus-host interactions in the course of HIV-1 infection. Immunol Rev 1994; 140:35-72.
6. Clerici M, Wynn TA, Berzofsky JA, Blatt SP, Hendrix CW, Sher A, Coffman RL, Shearer GM. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93:768-75.
7. Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ. The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol 1987; 110:140-8.
8. Gilbert M, Kirihara J, Mills J. Enzyme-linked immunoassay for human immunodeficiency virus type 1 envelope glycoprotein 120. J Clin Microbiol 1991; 29:142-7.
9. Oh SK, Cruikshank WW, Raina J, Blanchard GC, Adler WH, Walker J, Kornfeld H. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 1992; 5:251-6.
10. Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ. HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 1987; 138:2640-4.
11. + T lymphocytes by inhibiting interleukin 2 mRNA. Proc Natl Acad Sci USA 1990; 87:2379-83.
12. Chirmule N, Kalyanaraman VS, Oyaizu N, Slade HB, Pahwa S. Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus. Blood 1990; 75:152-9.
13. Liegler TJ, Stites DP. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J Acquir Immune Defic Syndr 1994; 7:340-8.
14. + T cells by stimulation through the CD28 pathway. Clin Exp Immunol 1996; 105:225-30.
15. Schols D, De Clereq E. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J Virol 1996; 70:4953-60.
16. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekally R-P, Finkel TH. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 1992; 176:1099-106.
17. Sekigawa I, Hishikawa T, Kaneko H, Hashimoto H, Hirose S, Ingaki Y, Yamamoto N. FK506 can inhibit apoptotic cell death induced by the HIV-1 envelope glycoprotein gp120. AIDS 1994; 8:1623-4.
18. Sekigawa I, Koshino K, Hishikawa T et al. Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. J Clin Immunol 1995; 15:312-7.
19. Merrill JE, Koyanagi Y, Chen ISY. Interleukin-1 and tumor necrosis factor a can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989; 63:4404-8.
20. Wahl LM, Corcoran ML, Pyle SW, Arthur LO, Harel-Bellan A, Farrar WL. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc Natl Acad Sci USA 1989; 86:621-5.
21. Clouse KA, Cosentino LM, Weih KA, Pyle SW, Robbins PB, Hochstein HD, Natarajan V, Farrar WL. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J Immunol 1991; 147:2892-901.
22. Francis ML, Meltzer MS. Induction of IFN-α by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication. J Immunol 1993; 151:2208-16.
23. Ameglio F, Capobianchi MR, Castilletti C, Cordiali Fei P, Fais S, Trento E, Dianzani F. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells; correlation with the induction of other cytokines. Clin Exp Immunol 1994; 95:455-8.
24. Karsten V, Gordon S, Kirn A, Herbein G. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-α. Immunology 1996; 88:55-60.
25. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc Natl Acad Sci USA 1989; 86:2336-40.
26. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990; 11:176-80.
27. Matsuyama T, Kobayashi N, Yamamoto N. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 1991; 5:1405-17.
28. Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S. Membrane tumour necrosis factor-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 1993; 363:464-6.
29. Lähdevirta J, Maury CP, Teppo A-M, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:289-91.
30. + T cells and deficient interleukin-2 production in patients with systlemic lupus erythematosus. Clin Immunol Immunopathol 1990; 55:285-96.
31. Freedman AS, Rhynhart K, Nojima Y, Svahn J, Eliseo L, Benjamin CD, Morimoto C, Vivier E. Stimulation of protein tyrosine phosphorylation in human B cells after ligation of the β1 integrin VLA-4. J Immunol 1993; 150:1645-52.
32. Neoh LP, Akimoto H, Kaneko H et al. The production of β-chemokines induced by HIV-2 envelope glycoprotein. AIDS 1997; in press.
33. Horak ID, Popovic M, Horak EM, Lucas PJ, Gress RE, June CH, Bolen JB. No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120. Nature 1990; 348:557-60.
34. lck with CD4 in human T lymphocytes. J Biol Chem 1991; 266:11176-83.
35. lck in human CD4 T lymphocytes. Eur J Immunol 1993; 23:600-7.
36. lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J Immunol 1994; 153:2905-17.
37. + T cells. Science 1995; 270:1811-5.
38. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature 1995; 378:563.
39. Wolf H, Muller Y, Salmen S, Wilmanns W, Jung G. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur J Immunol 1994; 24:1410-7.
40. Maruyama I, Maruyama Y, Nakajima T et al. Vesnarinone inhibits production of HIV-1 in cultured cells. Biochem Biophys Res Commun 1993; 195:1264-71.
41. Oyaizu N, McCloskey TW, Than S, Pahwa S. Inhibition of CD4 crosslinking-induced lymphocytes apoptosis by vesnarinone as a novel immunomodulating agent: vesnarinone inhibits Fas expression and apoptosis by blocking cytokine secretion. Blood 1996; 87:2361-8.